 | • レポートコード：QFJ1-5651 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、86ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、セルトリズマブペゴルの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（単回投与バイアル、単回投与プレフィルドシリンジ）、用途別市場規模（クローン病、活動性関節リウマチ、活動性乾癬性関節炎）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・セルトリズマブペゴルの市場動向 ・企業の競争状況、市場シェア ・セルトリズマブペゴルの種類別市場規模と予測2016-2027（単回投与バイアル、単回投与プレフィルドシリンジ） ・セルトリズマブペゴルの用途別市場規模と予測2016-2027（クローン病、活動性関節リウマチ、活動性乾癬性関節炎） ・セルトリズマブペゴルの北米市場規模2016-2027（アメリカ、カナダ） ・セルトリズマブペゴルの欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・セルトリズマブペゴルのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・セルトリズマブペゴルの中南米市場規模2016-2027（メキシコ、ブラジル） ・セルトリズマブペゴルの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（UCB） ・結論 |
Certolizumab pegol (CDP870, tradename Cimzia) is a biologic medication for the treatment of Crohn’s disease, rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis.
Market Analysis and Insights: Global Certolizumab pegol Market
The global Certolizumab pegol market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Certolizumab pegol market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Certolizumab pegol market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Certolizumab pegol market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Certolizumab pegol market.
Global Certolizumab pegol Scope and Market Size
Certolizumab pegol market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Certolizumab pegol market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Single-dose vial
Single-dose prefilled syringe
Segment by Application
Crohn’s disease
Active rheumatoid arthritis
Active psoriatic arthritis
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
UCB
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Certolizumab pegol Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Single-dose vial
1.2.3 Single-dose prefilled syringe
1.3 Market by Application
1.3.1 Global Certolizumab pegol Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Crohn’s disease
1.3.3 Active rheumatoid arthritis
1.3.4 Active psoriatic arthritis
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Certolizumab pegol Market Perspective (2016-2027)
2.2 Certolizumab pegol Growth Trends by Regions
2.2.1 Certolizumab pegol Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Certolizumab pegol Historic Market Share by Regions (2016-2021)
2.2.3 Certolizumab pegol Forecasted Market Size by Regions (2022-2027)
2.3 Certolizumab pegol Industry Dynamic
2.3.1 Certolizumab pegol Market Trends
2.3.2 Certolizumab pegol Market Drivers
2.3.3 Certolizumab pegol Market Challenges
2.3.4 Certolizumab pegol Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Certolizumab pegol Players by Revenue
3.1.1 Global Top Certolizumab pegol Players by Revenue (2016-2021)
3.1.2 Global Certolizumab pegol Revenue Market Share by Players (2016-2021)
3.2 Global Certolizumab pegol Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Certolizumab pegol Revenue
3.4 Global Certolizumab pegol Market Concentration Ratio
3.4.1 Global Certolizumab pegol Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Certolizumab pegol Revenue in 2020
3.5 Certolizumab pegol Key Players Head office and Area Served
3.6 Key Players Certolizumab pegol Product Solution and Service
3.7 Date of Enter into Certolizumab pegol Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Certolizumab pegol Breakdown Data by Type
4.1 Global Certolizumab pegol Historic Market Size by Type (2016-2021)
4.2 Global Certolizumab pegol Forecasted Market Size by Type (2022-2027)
5 Certolizumab pegol Breakdown Data by Application
5.1 Global Certolizumab pegol Historic Market Size by Application (2016-2021)
5.2 Global Certolizumab pegol Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Certolizumab pegol Market Size (2016-2027)
6.2 North America Certolizumab pegol Market Size by Type
6.2.1 North America Certolizumab pegol Market Size by Type (2016-2021)
6.2.2 North America Certolizumab pegol Market Size by Type (2022-2027)
6.2.3 North America Certolizumab pegol Market Size by Type (2016-2027)
6.3 North America Certolizumab pegol Market Size by Application
6.3.1 North America Certolizumab pegol Market Size by Application (2016-2021)
6.3.2 North America Certolizumab pegol Market Size by Application (2022-2027)
6.3.3 North America Certolizumab pegol Market Size by Application (2016-2027)
6.4 North America Certolizumab pegol Market Size by Country
6.4.1 North America Certolizumab pegol Market Size by Country (2016-2021)
6.4.2 North America Certolizumab pegol Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Certolizumab pegol Market Size (2016-2027)
7.2 Europe Certolizumab pegol Market Size by Type
7.2.1 Europe Certolizumab pegol Market Size by Type (2016-2021)
7.2.2 Europe Certolizumab pegol Market Size by Type (2022-2027)
7.2.3 Europe Certolizumab pegol Market Size by Type (2016-2027)
7.3 Europe Certolizumab pegol Market Size by Application
7.3.1 Europe Certolizumab pegol Market Size by Application (2016-2021)
7.3.2 Europe Certolizumab pegol Market Size by Application (2022-2027)
7.3.3 Europe Certolizumab pegol Market Size by Application (2016-2027)
7.4 Europe Certolizumab pegol Market Size by Country
7.4.1 Europe Certolizumab pegol Market Size by Country (2016-2021)
7.4.2 Europe Certolizumab pegol Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Certolizumab pegol Market Size (2016-2027)
8.2 Asia-Pacific Certolizumab pegol Market Size by Type
8.2.1 Asia-Pacific Certolizumab pegol Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Certolizumab pegol Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Certolizumab pegol Market Size by Type (2016-2027)
8.3 Asia-Pacific Certolizumab pegol Market Size by Application
8.3.1 Asia-Pacific Certolizumab pegol Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Certolizumab pegol Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Certolizumab pegol Market Size by Application (2016-2027)
8.4 Asia-Pacific Certolizumab pegol Market Size by Region
8.4.1 Asia-Pacific Certolizumab pegol Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Certolizumab pegol Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Certolizumab pegol Market Size (2016-2027)
9.2 Latin America Certolizumab pegol Market Size by Type
9.2.1 Latin America Certolizumab pegol Market Size by Type (2016-2021)
9.2.2 Latin America Certolizumab pegol Market Size by Type (2022-2027)
9.2.3 Latin America Certolizumab pegol Market Size by Type (2016-2027)
9.3 Latin America Certolizumab pegol Market Size by Application
9.3.1 Latin America Certolizumab pegol Market Size by Application (2016-2021)
9.3.2 Latin America Certolizumab pegol Market Size by Application (2022-2027)
9.3.3 Latin America Certolizumab pegol Market Size by Application (2016-2027)
9.4 Latin America Certolizumab pegol Market Size by Country
9.4.1 Latin America Certolizumab pegol Market Size by Country (2016-2021)
9.4.2 Latin America Certolizumab pegol Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Certolizumab pegol Market Size (2016-2027)
10.2 Middle East & Africa Certolizumab pegol Market Size by Type
10.2.1 Middle East & Africa Certolizumab pegol Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Certolizumab pegol Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Certolizumab pegol Market Size by Type (2016-2027)
10.3 Middle East & Africa Certolizumab pegol Market Size by Application
10.3.1 Middle East & Africa Certolizumab pegol Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Certolizumab pegol Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Certolizumab pegol Market Size by Application (2016-2027)
10.4 Middle East & Africa Certolizumab pegol Market Size by Country
10.4.1 Middle East & Africa Certolizumab pegol Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Certolizumab pegol Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 UCB
11.1.1 UCB Company Details
11.1.2 UCB Business Overview
11.1.3 UCB Certolizumab pegol Introduction
11.1.4 UCB Revenue in Certolizumab pegol Business (2016-2021)
11.1.5 UCB Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Certolizumab pegol Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Single-dose vial
Table 3. Key Players of Single-dose prefilled syringe
Table 4. Global Certolizumab pegol Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Certolizumab pegol Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Certolizumab pegol Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Certolizumab pegol Market Share by Regions (2016-2021)
Table 8. Global Certolizumab pegol Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Certolizumab pegol Market Share by Regions (2022-2027)
Table 10. Certolizumab pegol Market Trends
Table 11. Certolizumab pegol Market Drivers
Table 12. Certolizumab pegol Market Challenges
Table 13. Certolizumab pegol Market Restraints
Table 14. Global Certolizumab pegol Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Certolizumab pegol Market Share by Players (2016-2021)
Table 16. Global Top Certolizumab pegol Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Certolizumab pegol as of 2020)
Table 17. Ranking of Global Top Certolizumab pegol Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Certolizumab pegol Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Certolizumab pegol Product Solution and Service
Table 21. Date of Enter into Certolizumab pegol Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Certolizumab pegol Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Certolizumab pegol Revenue Market Share by Type (2016-2021)
Table 25. Global Certolizumab pegol Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Certolizumab pegol Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Certolizumab pegol Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Certolizumab pegol Revenue Market Share by Application (2016-2021)
Table 29. Global Certolizumab pegol Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Certolizumab pegol Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Certolizumab pegol Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Certolizumab pegol Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Certolizumab pegol Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Certolizumab pegol Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Certolizumab pegol Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Certolizumab pegol Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Certolizumab pegol Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Certolizumab pegol Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Certolizumab pegol Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Certolizumab pegol Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Certolizumab pegol Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Certolizumab pegol Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Certolizumab pegol Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Certolizumab pegol Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Certolizumab pegol Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Certolizumab pegol Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Certolizumab pegol Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Certolizumab pegol Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Certolizumab pegol Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Certolizumab pegol Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Certolizumab pegol Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Certolizumab pegol Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Certolizumab pegol Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Certolizumab pegol Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Certolizumab pegol Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Certolizumab pegol Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Certolizumab pegol Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Certolizumab pegol Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Certolizumab pegol Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Certolizumab pegol Market Size by Country (2022-2027) & (US$ Million)
Table 61. UCB Company Details
Table 62. UCB Business Overview
Table 63. UCB Certolizumab pegol Product
Table 64. UCB Revenue in Certolizumab pegol Business (2016-2021) & (US$ Million)
Table 65. UCB Recent Development
Table 66. Research Programs/Design for This Report
Table 67. Key Data Information from Secondary Sources
Table 68. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Certolizumab pegol Market Share by Type: 2020 VS 2027
Figure 2. Single-dose vial Features
Figure 3. Single-dose prefilled syringe Features
Figure 4. Global Certolizumab pegol Market Share by Application: 2020 VS 2027
Figure 5. Crohn’s disease Case Studies
Figure 6. Active rheumatoid arthritis Case Studies
Figure 7. Active psoriatic arthritis Case Studies
Figure 8. Certolizumab pegol Report Years Considered
Figure 9. Global Certolizumab pegol Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Certolizumab pegol Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Certolizumab pegol Market Share by Regions: 2020 VS 2027
Figure 12. Global Certolizumab pegol Market Share by Regions (2022-2027)
Figure 13. Global Certolizumab pegol Market Share by Players in 2020
Figure 14. Global Top Certolizumab pegol Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Certolizumab pegol as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Certolizumab pegol Revenue in 2020
Figure 16. Global Certolizumab pegol Revenue Market Share by Type (2016-2021)
Figure 17. Global Certolizumab pegol Revenue Market Share by Type (2022-2027)
Figure 18. North America Certolizumab pegol Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Certolizumab pegol Market Share by Type (2016-2027)
Figure 20. North America Certolizumab pegol Market Share by Application (2016-2027)
Figure 21. North America Certolizumab pegol Market Share by Country (2016-2027)
Figure 22. United States Certolizumab pegol Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Certolizumab pegol Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Certolizumab pegol Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Certolizumab pegol Market Share by Type (2016-2027)
Figure 26. Europe Certolizumab pegol Market Share by Application (2016-2027)
Figure 27. Europe Certolizumab pegol Market Share by Country (2016-2027)
Figure 28. Germany Certolizumab pegol Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Certolizumab pegol Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Certolizumab pegol Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Certolizumab pegol Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Certolizumab pegol Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Certolizumab pegol Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Certolizumab pegol Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Certolizumab pegol Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Certolizumab pegol Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Certolizumab pegol Market Share by Region (2016-2027)
Figure 38. China Certolizumab pegol Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Certolizumab pegol Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Certolizumab pegol Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Certolizumab pegol Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Certolizumab pegol Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Certolizumab pegol Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Certolizumab pegol Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Certolizumab pegol Market Share by Type (2016-2027)
Figure 46. Latin America Certolizumab pegol Market Share by Application (2016-2027)
Figure 47. Latin America Certolizumab pegol Market Share by Country (2016-2027)
Figure 48. Mexico Certolizumab pegol Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Certolizumab pegol Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Certolizumab pegol Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Certolizumab pegol Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Certolizumab pegol Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Certolizumab pegol Market Share by Country (2016-2027)
Figure 54. Turkey Certolizumab pegol Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Certolizumab pegol Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Certolizumab pegol Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UCB Revenue Growth Rate in Certolizumab pegol Business (2016-2021)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
世界の関節リウマチ診断装置市場規模・現状・予測（2021年-2027年） Rheumatoid Arthritis Diagnostic Device is equipment for Rheumatoid Arthritis Diagnostic. The rising incidence of rheumatoid arthritis has prompted various healthcare organizations and governments to raise awareness about the condition and its treatment plans and diagnostic procedures. Also, in the m…- 世界の単回照射放射線療法市場規模・現状・予測（2021年-2027年） Single dose radiotherapy has been pitched as an alternative to the conventional radiotherapy for cancer treatment. It has many advantages like less number of visits to the clinic, affordability, less side effects among others. Market Analysis and Insights: Global Single Dose Radiotherapy Market The …
- 世界の関節炎モノクローナル抗体市場規模・現状・予測（2021年-2027年） Arthritis Monoclonal Antibodies are a group of complex and effective biological agents used to treat arthritis and other immune-mediated inflammatory diseases Market Analysis and Insights: Global Arthritis Monoclonal Antibodies Market The global Arthritis Monoclonal Antibodies market size is project…
- 世界の犬用関節炎治療薬市場規模・現状・予測（2021年-2027年） The canine arthritis treatment types include non-steroidal anti-inflammatory medications (NSAIDs), opioids and stem cell Canine Arthritis Treatment. Non-steroidal anti-inflammatory Canine Arthritis Treatment are used to control pain and inflammation associated with arthritis. They are most commonly …
- 関節リウマチ診断装置のグローバル市場：規模・現状・予測2019-2025 Rheumatoid Arthritis Diagnostic Device is equipment for Rheumatoid Arthritis Diagnostic.The rising incidence of rheumatoid arthritis has prompted various healthcare organizations and governments to raise awareness about the condition and its treatment plans and diagnostic procedures. Also, in the ma…